Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemiasZhihong Zeng, Marina Konopleva, Michael Andreeff et al.|Molecular Cancer Therapeutics|2006Cited by 186
Exploring the Stereochemistry of CXCR4-Peptide Recognition and Inhibiting HIV-1 Entry with d-Peptides Derived from ChemokinesNaiming Zhou, Ziwei Huang, Zhaowen Luo et al.|Journal of Biological Chemistry|2002Cited by 117
Unique Ligand Binding Sites on CXCR4 Probed by a Chemical Biology Approach: Implications for the Design of Selective Human Immunodeficiency Virus Type 1 InhibitorsWon‐Tak Choi, Ziwei Huang, Joseph Sodroski et al.|Journal of Virology|2005Cited by 71
Enhancement of Radiation Sensitivity in Lung Cancer Cells by a Novel Small Molecule Inhibitor That Targets the β-Catenin/Tcf4 InteractionQinghao Zhang, Jing An|PLoS ONE|2016Cited by 20
High affinity CXCR4 inhibitors generated by linking low affinity peptidesChaozai Zhang, Jing An|European Journal of Medicinal Chemistry|2019Cited by 11